MARKET

CHMA

CHMA

Chiasma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.29
+0.02
+0.38%
Closed 16:00 11/12 EST
OPEN
5.28
PREV CLOSE
5.27
HIGH
5.44
LOW
5.15
VOLUME
79.89K
TURNOVER
--
52 WEEK HIGH
9.25
52 WEEK LOW
2.110
MARKET CAP
222.27M
P/E (TTM)
-4.6579
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CHMA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CHMA News

  • Edited Transcript of CHMA earnings conference call or presentation 5-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.17h ago
  • Hedge Funds Have Never Been More Bullish On Chiasma Inc (CHMA)
  • Insider Monkey.1d ago
  • Chiasma (CHMA) Investor Presentation - Slideshow
  • Seeking Alpha - Article.6d ago
  • Chiasma, Inc. (CHMA) CEO Raj Kannan on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.6d ago

More

Industry

Pharmaceuticals
+0.28%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About CHMA

Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion. The Company is developing octreotide capsules as a liquid-filled solid gelatin capsule formulation, which is intended to be taken over twice a day. The Company's TPE technology enhances the absorption through the intestinal wall of drugs. The Company also focuses on developing CH2 for Orphan indication.
More

Webull offers Chiasma Inc (CHMA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.